TAK-1/p38/nNFκB signaling inhibits myoblast differentiation by increasing levels of Activin A
Anne U. Trendelenburg(Novartis (Switzerland)), David J. Glass(Regeneron (United States))
Cited by 103
Related Papers
Activin type II receptor signaling in cardiac aging and heart failure
|Science Translational Medicine|2019|147
Inhibition of mTORC1 signaling in aged rats counteracts the decline in muscle mass and reverses multiple parameters of muscle signaling associated with sarcopenia
|bioRxiv (Cold Spring Harbor Laboratory)|2019|7